Fujian Wanchen Biotechnology Group Co.,Ltd. (SHE:300972)

SHE:300972 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	4,193	2,381	1,210	115.04	216.21	33.54
Trading Asset Securities	-	-	-	-	20.03	-
Cash & Short-Term Investments	4,193	2,381	1,210	115.04	236.24	33.54
Cash Growth	82.87%	96.80%	951.57%	-51.30%	604.37%	23.52%
Accounts Receivable	17.54	19.42	27.17	14.59	9.57	2.37
Other Receivables	56.63	66.05	122.87	4.61	0.57	0.3
Receivables	74.17	85.47	150.05	19.2	10.13	2.67
Inventory	2,401	2,141	733.29	100.11	55.37	50.8
Prepaid Expenses	1,241	-	-	1.48	-	-
Other Current Assets	53.69	1,163	256.2	42.87	0.64	6.12
Total Current Assets	7,963	5,771	2,349	278.69	302.39	93.13
Property, Plant & Equipment	1,050	1,271	1,371	796.9	506.33	506.01
Long-Term Investments	-	-	-	0.24	-	-
Other Intangible Assets	82.25	59.52	60.59	53.04	53.41	54.82
Long-Term Accounts Receivable	2.08	3.02	0.73	0.12	-	-
Long-Term Deferred Tax Assets	72.99	95.12	74.64	11.9	-	-
Long-Term Deferred Charges	29.68	37.5	51.2	4.9	-	-
Other Long-Term Assets	11.75	16.79	18.07	55.35	1.05	4.31
Total Assets	9,212	7,253	3,925	1,201	863.18	658.27
Accounts Payable	2,665	2,094	943.17	117.38	59.68	39.47
Accrued Expenses	124.81	301.32	115.67	27.06	13.18	12.4
Short-Term Debt	777.21	956.01	510.77	148.37	64.78	88.06
Current Portion of Long-Term Debt	179.19	12.67	9.28	6.54	30.04	61.39
Current Portion of Leases	-	155	146.03	16.17	0.08	-
Current Income Taxes Payable	308.49	208.09	54.68	0.01	5.61	-
Current Unearned Revenue	286.47	312.17	169.71	8.93	1.17	4.21
Other Current Liabilities	1,184	1,089	690.9	7.03	6	6.92
Total Current Liabilities	5,526	5,128	2,640	331.49	180.54	212.46
Long-Term Debt	296.32	237.48	148.35	110.5	-	30
Long-Term Leases	188.99	299.21	324.81	31.24	0.17	-
Long-Term Unearned Revenue	32.94	36.12	40.45	43.62	29.77	15.16
Long-Term Deferred Tax Liabilities	68.23	91.17	75.72	11.93	-	-
Total Liabilities	6,112	5,792	3,230	528.79	210.47	257.61
Common Stock	188.89	179.99	154.69	153.5	153.5	115.13
Additional Paid-In Capital	685.79	534.07	364.09	305.15	303.67	113.44
Retained Earnings	1,167	384.1	126.58	209.5	195.54	172.09
Total Common Equity	2,042	1,098	645.36	668.15	652.71	400.65
Minority Interest	1,058	363.19	50.45	4.21	-	-
Shareholders' Equity	3,100	1,461	695.81	672.36	652.71	400.65
Total Liabilities & Equity	9,212	7,253	3,925	1,201	863.18	658.27
Total Debt	1,442	1,660	1,139	312.82	95.07	179.44
Net Cash (Debt)	2,751	720.24	70.45	-197.78	141.18	-145.9
Net Cash Growth	275.39%	922.33%	-	-	-	-
Net Cash Per Share	13.81	3.85	0.46	-1.27	1.00	-1.27
Filing Date Shares Outstanding	188.89	179.99	172.39	153.5	153.5	115.13
Total Common Shares Outstanding	188.89	179.99	154.69	153.5	153.5	115.13
Working Capital	2,437	642.52	-290.99	-52.8	121.85	-119.33
Book Value Per Share	10.81	6.10	4.17	4.35	4.25	3.48
Tangible Book Value	1,960	1,039	584.77	615.11	599.3	345.84
Tangible Book Value Per Share	10.37	5.77	3.78	4.01	3.90	3.00
Buildings	-	616.41	613.66	370.04	368.64	365.76
Machinery	-	734.41	698.29	446.97	433.87	418.33
Construction In Progress	-	1.1	1.24	302.84	35.05	3.36

Source: S&P Global Market Intelligence. Standard template. Financial Sources.